Future Health Care Equity ETF

Profitability for 1 year: 20.35%
Commission: 0.75%
Category: Health & Biotech Equities

36.28 $

+0.08 $ +0.22%
28.84 $
37.25 $

Min/max per year

Main settings

10 year return 0
3 year return 0
5 year return 0
Annual return 16.24
Asset size Multi-Cap
Asset type Equity
Average P/BV 5.77
Average P/E 30.6
Average P/S 4.43
Commission 0.75
Country USA
Currency usd
Div. yield 0.85
Focus Health Care
Foundation date 2021-11-09
ISIN code US38149W7700
ISO country US
Index ACTIVE - No Index
Number of companies 40
Owner Goldman Sachs
Region Global
Region Broad
Strategy Active
Website link
segment Equity: Global Health Care Technology
Change per day +0.22% 36.195 $
Change per week +1.12% 35.8731 $
Change per month +0.45% 36.111 $
Change per 3 month +5.36% 34.431 $
Change per half year +11.62% 32.5 $
Change per year +20.35% 30.142 $
Change per year to date -0.26% 36.368 $

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Similar ETF

Other ETFs from the Management Company

Title Class Category Commission Annual return
Equity 0.19 28.68
Bond 0.12 -0.12
Equity 0.25 20.35
Equity 0.07 31.41
Equity 0.11 31.21
Equity 0.45 33.66
Equity 0.25 14.27
Equity 0.2 20.75
Commodity 0.18 31.29
Equity 0.09 21.55
Bond 0.16 0.23
Equity 0.2 32.14
Bond 0.14 2.34
Equity 0.52 34.28
Equity 0.2 31.43
Equity 0.45 38.38
Equity 0.75 49.52
Bond 0.34 4.08
Bond 0.12 0.26
Equity 0.36 32.97
Equity 0.75 20.21
Bond 0.39 7.14
Equity 0.75 12.23
Equity 0.75 29.65
Equity 0.25 23.8
Equity 0.75 -2.95
Equity 0.45 -3.03
Equity 0.25 18.2
Bond 0.15 5.4

Description Future Health Care Equity ETF

The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.